![]() |
|
|
Vol. 60, Issue 1, 135-142, July 2001
Department of Pharmaceutical Biosciences, Division of Toxicology,
Biomedical Centre, Uppsala University, Uppsala, Sweden
To identify genes that are regulated by
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and possibly
involved in TCDD-induced immunotoxicity, we used the differential
display technique to screen for differentially expressed genes in the
mouse thymus. Here we show that TCDD increased the expression of
adseverin, a Ca2+-dependent, actin-severing protein. The
induction of adseverin is dose- and time-dependent in parallel with the
induction of CYP1A1, which is currently the most frequently used marker
for TCDD exposure. A comparison between mouse strains with different TCDD responsiveness indicated that the induction of adseverin is
dependent on the aryl hydrocarbon receptor, a transcription factor
known to mediate most of TCDD's biological effects. Examination of
additional organs revealed that the up-regulation of the adseverin gene
expression is immune-specific. Using an anti-adseverin antibody, we
confirmed the induction of adseverin by TCDD at the protein level and
it was confined to the thymic cortex, which harbors immature thymocytes
that are known target cells of TCDD. Considering adseverin's role in
actin cytoskeletal reorganization, our observations reveal new
mechanistic aspects of how TCDD might exert some of its immunotoxic effects.
This article has been cited by other articles:
![]() |
S. Jia, M. Omelchenko, D. Garland, V. Vasiliou, J. Kanungo, M. Spencer, Y. Wolf, E. Koonin, and J. Piatigorsky Duplicated gelsolin family genes in zebrafish: a novel scinderin-like gene (scinla) encodes the major corneal crystallin FASEB J, October 1, 2007; 21(12): 3318 - 3328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Laiosa, A. Wyman, F. G. Murante, N. C. Fiore, J. E. Staples, T. A. Gasiewicz, and A. E. Silverstone Cell Proliferation Arrest within Intrathymic Lymphocyte Progenitor Cells Causes Thymic Atrophy Mediated by the Aryl Hydrocarbon Receptor J. Immunol., November 1, 2003; 171(9): 4582 - 4591. [Abstract] [Full Text] [PDF] |
||||